Thomas J. Turbyville, Ph.D.
Affiliations: | 2005 | University of Arizona, Tucson, AZ |
Area:
Molecular Biology, OncologyGoogle:
"Thomas Turbyville"Parents
Sign in to add mentorLuke J. Whitesell | grad student | 2005 | University of Arizona | |
(Using phylogenetically conserved stress responses to discover natural products with anticancer activity.) | ||||
John Albert Beutler | post-doc | 2005-2008 | National Cancer Institute (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nelson AC, Turbyville TJ, Dharmaiah S, et al. (2020) internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling. The Journal of Biological Chemistry |
Goswami D, Chen D, Columbus J, et al. (2020) Abstract IA07: KRAS4b’s unique diffusion behavior is defined by plasma membrane and effector interactions Molecular Cancer Research. 18 |
Goswami D, Chen D, Columbus J, et al. (2020) Abstract A09: Cooperative membrane interaction between G-domain and HVR defines unique diffusion behavior of KRAS4b Molecular Cancer Research. 18 |
Columbus J, Turbyville TJ, Wall V, et al. (2020) Abstract LB-062: A live-cell, protein-protein interaction assay identified inhibitors of KRAS4b-G12D interaction with full-length RAF1 Cancer Research. 80 |
Esposito D, Stephen AG, Turbyville TJ, et al. (2018) New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics. Seminars in Cancer Biology |
Caropreso V, Darvishi E, Turbyville TJ, et al. (2016) Englerin A inhibits EWS-FLI1 DNA Binding in Ewings Sarcoma Cells. The Journal of Biological Chemistry |
Brafman A, Gudla P, Nandy K, et al. (2015) Abstract 4542: Targeting KRAS4b plasma membrane localization in cells Cancer Research. 75: 4542-4542 |
Ye X, Chan KC, Turbyville TJ, et al. (2015) Abstract 1996: Surface proteomics of KRASG12V transfected MCF10A cells reveals molecular phenotype of a model cell line expressing oncogenic KRAS Cancer Research. 75: 1996-1996 |
Ye X, Turbyville TJ, Bagni R, et al. (2015) Abstract 1829: Comparative surface proteomics of NCI-H2122 cells reveals distinct cell surface phenotype of a metastatic NSCLC cell line expressing oncogenic KRASG12C Cancer Research. 75: 1829-1829 |
Lockett S, Verma C, Brafman A, et al. (2014) Quantitative analysis of F-actin redistribution in astrocytoma cells treated with candidate pharmaceuticals. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 85: 512-21 |